Dose‐ and Time‐Dependent Characterization of Doxorubicin‐Induced Podocytopathy: Defining the Transition From Functional Impairment to Structural Damage

Doxorubicin (DOX) clinical utility is limited by dose-dependent cardiotoxicity and nephrotoxicity. Although DOX-induced podocytopathy has been widely studied, variability in dosing regimens has limited the definition of the transition from early functional impairment to structural podocyte injury. This study characterized the dose- and time-dependent progression of DOX-induced nephrotoxicity and defined this functional-to-structural transition. Wistar rats received DOX (0, 2, 5, or 7.5 mg/kg) using a two-phase experimental design. Renal injury was assessed by urinary protein excretion, microalbuminuria, albumin-to-creatinine ratio (ACR), and serum biochemical parameters. Renal histopathology was evaluated by light microscopy, while transmission electron microscopy (TEM) assessed glomerular ultrastructural alterations, including slit pore diameter, glomerular basement membrane thickness, and podocyte foot process base width. DOX induced dose- and time-dependent renal injury. The 2 mg/kg dose produced minimal and transient changes. At 5 mg/kg, DOX caused early functional impairment characterized by marked proteinuria (p < 0.001), increased ACR, and mild hypoalbuminemia (p < 0.05), without detectable structural abnormalities by light microscopy. In contrast, 7.5 mg/kg produced severe renal injury characterized by heavy proteinuria, profound hypoalbuminemia, hypercholesterolemia, and progressive glomerular injury. TEM demonstrated marked podocyte foot process effacement and ultrastructural glomerular alterations. Microalbuminuria and ACR increased progressively with DOX-induced renal injury. DOX-induced nephrotoxicity demonstrated a distinct dose-dependent transition from functional impairment at 5 mg/kg to severe structural podocyte injury at 7.5 mg/kg. ACR provided a creatinine-normalized measure of albuminuria and increased substantially during established renal injury. This model provides a useful framework for investigating progressive DOX-induced podocytopathy and evaluating potential nephroprotective interventions.

Authors

Institutions

Publication Details

Journal
Journal of Biochemical and Molecular Toxicology
Published
2026-11-18
DOI
https://doi.org/10.1002/jbt.71184
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dose‐ and Time‐Dependent Characterization of Doxorubicin‐Induced Podocytopathy: Defining the Transition From Functional Impairment to Structural Damage

Ramchandra K. Ranvir, Amit Arvind Joharapurkar, Chirag Amrutlal Patel, Mukul Rameshchandra Jain et al.
Journal of Biochemical and Molecular Toxicology
Renal Diseases and Glomerulopathies
article

Dose‐ and Time‐Dependent Characterization of Doxorubicin‐Induced Podocytopathy: Defining the Transition From Functional Impairment to Structural Damage

Ramchandra K. Ranvir, Amit Arvind Joharapurkar, Chirag Amrutlal Patel, Mukul Rameshchandra Jain, Vishal J. Patel, Dinesh Patel, Shital Patel, Jitendra Patel, Sudhirkumar Patel, S. Rajesh Sundar, Mehul Upadhyay, Urvit Patel, Tushar Patel
article en

Abstract

Doxorubicin (DOX) clinical utility is limited by dose-dependent cardiotoxicity and nephrotoxicity. Although DOX-induced podocytopathy has been widely studied, variability in dosing regimens has limited the definition of the transition from early functional impairment to structural podocyte injury. This study characterized the dose- and time-dependent progression of DOX-induced nephrotoxicity and defined this functional-to-structural transition. Wistar rats received DOX (0, 2, 5, or 7.5 mg/kg) using a two-phase experimental design. Renal injury was assessed by urinary protein excretion, microalbuminuria, albumin-to-creatinine ratio (ACR), and serum biochemical parameters. Renal histopathology was evaluated by light microscopy, while transmission electron microscopy (TEM) assessed glomerular ultrastructural alterations, including slit pore diameter, glomerular basement membrane thickness, and podocyte foot process base width. DOX induced dose- and time-dependent renal injury. The 2 mg/kg dose produced minimal and transient changes. At 5 mg/kg, DOX caused early functional impairment characterized by marked proteinuria (p < 0.001), increased ACR, and mild hypoalbuminemia (p < 0.05), without detectable structural abnormalities by light microscopy. In contrast, 7.5 mg/kg produced severe renal injury characterized by heavy proteinuria, profound hypoalbuminemia, hypercholesterolemia, and progressive glomerular injury. TEM demonstrated marked podocyte foot process effacement and ultrastructural glomerular alterations. Microalbuminuria and ACR increased progressively with DOX-induced renal injury. DOX-induced nephrotoxicity demonstrated a distinct dose-dependent transition from functional impairment at 5 mg/kg to severe structural podocyte injury at 7.5 mg/kg. ACR provided a creatinine-normalized measure of albuminuria and increased substantially during established renal injury. This model provides a useful framework for investigating progressive DOX-induced podocytopathy and evaluating potential nephroprotective interventions.

Journal of Biochemical and Molecular ToxicologyVol. 40(12)
Gujarat Technological University (IN), Zydus Lifesciences Limited (India) (IN)
Advanced Centre for Treatment, Research and Education in Cancer
Good health and well-being
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon